Anti Inflammatory News and Research

RSS

Antifungal agent Bifonazole as an antiviral against SARS-CoV-2

In a recent study published in the journal Molecular Therapy, researchers identified Bifonazole, an imidazole-based antifungal agent, to have potent activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using high-throughput screening of small molecules.

12 May 2022

Assessment of England's medication prescribing safety during COVID pandemic

In a recent study posted to the medRxiv* preprint server, researchers assessed the impact of coronavirus disease 2019 (COVID-19) on the prescribing safety of high-risk medications on a national scale in England.

11 May 2022

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

In this study, the authors have specifically studied the interactions of epithelial cells, a subset of cytokines and macrophages.

10 May 2022

Scientists explore immunopathology of COVID-19

Researchers explored the interactions between severe acute respiratory syndrome coronavirus 2 and the host in the development of COVID-19.

6 May 2022

Effects of diet on COVID-19 outcomes

A new study explores the effects of diet on COVID-19 outcomes.

5 May 2022

Study shows how a non-opioid approach successfully manages women's pain after C-section

For years, women recovering from cesarean section (C-section) deliveries have been given devices that let them, with a button, control the flow of opioid painkillers into their IV line. But as researchers and policymakers push to curb the use of opioids, clinicians are developing new strategies for treating pain after C-sections.

3 May 2022

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Researchers reviewed the potential clinically relevant mechanisms by which microbiota and microbiota-derived metabolites influence the host immune responses to SARS-CoV-2 infection.

3 May 2022

Antibiotics may disrupt microbiome to cause recurrent UTIs

A study by researchers at Washington University School of Medicine in St. Louis and the Broad Institute of MIT and Harvard suggests that women who get recurrent urinary tract infections (UTIs) may be caught in a vicious cycle in which antibiotics given to eradicate one infection predispose them to develop another.

2 May 2022

At US hospitals, a drug mix-up is just a few keystrokes away

More than four years ago, Tennessee nurse RaDonda Vaught typed two letters into a hospital's computerized medication cabinet, selected the wrong drug from the search results, and gave a patient a fatal dose.

29 Apr 2022

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

A recent study published in the journal Immunology analyzed whether sex mattered in the immune response to SARS-CoV-2.

29 Apr 2022

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

Researchers at Ural Federal University have proposed the use of polyoxometallate nanoclusters as a carrier for chemotherapy drug. It will help to deliver medications precisely to the focus of a pathological process, such as a cancerous tumor, without toxic effects on healthy cells.

28 Apr 2022

Review aims to deepen the understanding of the role of natural killer cells in COVID-19

In a recent study published in Biomedicines, researchers explored the utility of natural killer (NK) cells in coronavirus disease 2019 (COVID-19).

28 Apr 2022

New drug combo emerges as a potential candidate for oral pericoital contraception

A new combination of drugs has emerged as a "promising candidate" for an on-demand contraceptive pill, suggests preliminary research published online in the journal BMJ Sexual & Reproductive Health.

26 Apr 2022

Quercetin and other plant flavonols show anti-SARS-CoV-2 activity

A new study discusses the potential of certain plant compounds to block SARS-CoV-2 replication within host cells.

24 Apr 2022

Study highlights a rapidly increasing patient population with long COVID and lack of treatments

A new UK study of more than 2,000 patients after hospitalization with COVID-19 presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon 23-26), and published in The Lancet Respiratory Medicine shows that, one year after having COVID-19, only around one in four patients feel fully well again.

24 Apr 2022

Researchers identify cytokines that can help predict negative outcomes in COVID-19 patients

New research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal (23-26 April) has identified a panel of cytokines that can help predict which COVID-19 patients are at risk of serious illness and death.

23 Apr 2022

Anti Inflammatory News and Research

Antifungal agent Bifonazole as an antiviral against SARS-CoV-2

Assessment of England's medication prescribing safety during COVID pandemic

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

Scientists explore immunopathology of COVID-19

Effects of diet on COVID-19 outcomes

Study shows how a non-opioid approach successfully manages women's pain after C-section

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Antibiotics may disrupt microbiome to cause recurrent UTIs

At US hospitals, a drug mix-up is just a few keystrokes away

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

Review aims to deepen the understanding of the role of natural killer cells in COVID-19

New drug combo emerges as a potential candidate for oral pericoital contraception

Quercetin and other plant flavonols show anti-SARS-CoV-2 activity

Study highlights a rapidly increasing patient population with long COVID and lack of treatments

Researchers identify cytokines that can help predict negative outcomes in COVID-19 patients

An abnormally suppressed immune system may be to blame in some cases of long COVID-19

Study assesses whether early targeted treatment of patent ductus arteriosus improves outcomes in extreme preterm babies

How does SARS-CoV-2 infection affect the diversity of the gut microbiome?

Interleukin-3 may contribute to alleviating asthma, research suggests

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News